References
- Annual national data repot from KONOS transplantation analysis [updated 2020.03.16. Available from: https://www.konos.go.kr/konosis/common/bizlogic.jsp.
- Samuel SM, Tonelli MA, Foster BJ, Alexander RT, Nettel-Aguirre A, Soo A, et al. Survival in pediatric dialysis and transplant patients. Clin J Am Soc Nephrol 2011;6:1094-9. https://doi.org/10.2215/CJN.04920610
- Koukourgianni F, Harambat J, Ranchin B, Euvrard S, Bouvier R, Liutkus A, et al. Malignancy incidence after renal transplantation in children: a 20-year single-centre experience. Nephrol Dial Transplant 2010;25:611-6. https://doi.org/10.1093/ndt/gfp497
- Kim JH, Kim SS, Han DJ, Park SK. 49th European Renal Association-European dialysis and Transplant association Congress, Transplantation session: 502. 2012;94:847.
- Heo J, Noh OK, Oh YT, Chun M, Kim L. Cancer risk after renal transplantation in South Korea: a nationwide population-based study. BMC Nephrol 2018;19:311. https://doi.org/10.1186/s12882-018-1110-3
- Serrano OK, Bangdiwala AS, Vock DM, Chinnakotla S, Dunn TB, Finger EB, et al. Post-Transplant Malignancy after Pediatric Kidney Transplantation: Retrospective Analysis of Incidence and Risk Factors in 884 Patients Receiving Transplants Between 1963 and 2015 at the University of Minnesota. J Am Coll Surg 2017;225:181-93. https://doi.org/10.1016/j.jamcollsurg.2017.04.012
- You J, Kim M, Lee J, Han DJ, Park YS, Lee JH. Epstein-Barr virus infection in children with renal transplantation: A single-centre experience. Nephrology 2018;23:1039-45. https://doi.org/10.1111/nep.13162
- Dharnidharka VR, Araya CE. Post-transplant lymphoproliferative disease. Pediatr Nephrol 2009;24:731-6. https://doi.org/10.1007/s00467-007-0582-3
- Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep 2013;8:173-83. https://doi.org/10.1007/s11899-013-0162-5
- Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009;20:629-37. https://doi.org/10.1681/ASN.2008030287
- Kwon H, Kim YH, Choi JY, Sung S, Jung JH, Park S-K, et al. Analysis of 4000 kidney transplantations in a single center: Across immunological barriers. Medicine 2016;95:e4249. https://doi.org/10.1097/MD.0000000000004249
- Jeong HJ, Ahn YH, Park E, Choi Y, Yi NJ, Ko JS, et al. Posttransplantation lymphoproliferative disorder after pediatric solid organ transplantation: experiences of 20 years in a single center. Korean J Pediatr 2017;60:86-93. https://doi.org/10.3345/kjp.2017.60.3.86
- Hyun H, Park E, Cho M, Min SI, Ha J, Kang HJ, et al. Post-Transplant Lymphoproliferative Diseases in Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia. J Korean Med Sci 2019;34:e203. https://doi.org/10.3346/jkms.2019.34.e203
- Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2004;4:222-30. https://doi.org/10.1046/j.1600-6143.2003.00325.x
- Schober T, Framke T, Kreipe H, Schulz TF, Grohennig A, Hussein K, et al. Characteristics of Early and Late PTLD Development in Pediatric Solid Organ Transplant Recipients. Transplantation 2013;95.
- Mynarek M, Hussein K, Kreipe HH, Maecker-Kolhoff B. Malignancies after pediatric kidney transplantation: more than PTLD?. Pediatr Nephrol 2014;29:1517-28. https://doi.org/10.1007/s00467-013-2622-5
- Parker A, Bowles K, Bradley JA, Emery V, Featherstone C, Gupte G, et al. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines. Br J Haematol 2010;149:675-92. https://doi.org/10.1111/j.1365-2141.2010.08161.x
- Opelz G, Daniel V, Naujokat C, Dohler B. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma. Transplantation 2009;88:962-7. https://doi.org/10.1097/TP.0b013e3181b9692d
- Opelz G, Dohler B. Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report. Transplantation 2010;90:292-7. https://doi.org/10.1097/TP.0b013e3181e46a22
- Lustberg ME, Pelletier RP, Porcu P, Martin SI, Quinion CD, Geyer SM, et al. Human leukocyte antigen type and posttransplant lymphoproliferative disorder. Transplantation 2015;99:1220-5. https://doi.org/10.1097/TP.0000000000000487
- Pascual J. Post-transplant lymphoproliferative disorder--the potential of proliferation signal inhibitors. Nephrol Dial Transplant 2007;22 Suppl 1:i27-35. https://doi.org/10.1093/ndt/gfm088
- McDonald RA, Smith JM, Ho M, Lindblad R, Ikle D, Grimm P, et al. Incidence of PTLD in Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus and Steroids. Am J Transplant 2008;8:984-9. https://doi.org/10.1111/j.1600-6143.2008.02167.x
- Francis A, Johnson DW, Craig J, Teixeira-Pinto A, Wong G. Posttransplant lymphoproliferative disease may be an adverse risk factor for patient survival but not graft loss in kidney transplant recipients. Kidney Int 2018;94:809-17. https://doi.org/10.1016/j.kint.2018.06.009